• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Identification of luteinizing hormone-releasing factor and alpha subunit of glycoprotein hormones in ductal carcinoma of the mammary gland.

作者信息

Seppälä M, Wahlström T

出版信息

Int J Cancer. 1980 Sep 15;26(3):267-8. doi: 10.1002/ijc.2910260303.

DOI:10.1002/ijc.2910260303
PMID:6270004
Abstract

The immunoperoxidase technique was used to identify luteinizing hormone-releasing factor (LRF) and the alpha subunit of glycoprotein hormones in ductal carcinoma of the mammary gland. Eleven tumors were studied, using antisera against LRF and alpha subunit, and against the beta subunits of hCG, LH, FSH and TSH. Six of the tumors were both LRF- and alpha-positive and three were negative. One tumour was LRF-positive/alpha-negative, and one was LRF-negative/alpha-positive. None of the anti-beta subunit antisera gave positive staining, and normal breast tissue as well as chronic cystic mastopathy (five cases) were negative with all antisera tested. The results with the anti-alpha and anti-beta subunit antisera suggest that the material stained is free alpha subunit rather than any of the native glycoprotein hormones which share the common alpha subunit.

摘要

相似文献

1
Identification of luteinizing hormone-releasing factor and alpha subunit of glycoprotein hormones in ductal carcinoma of the mammary gland.
Int J Cancer. 1980 Sep 15;26(3):267-8. doi: 10.1002/ijc.2910260303.
2
Immunological evidence for the occurrence of luteinizing hormone-releasing factor and the alpha-subunit of glycoprotein hormones in carcinoid tumors.类癌肿瘤中促黄体生成素释放因子和糖蛋白激素α亚基存在的免疫学证据。
J Clin Endocrinol Metab. 1981 Jul;53(1):209-12. doi: 10.1210/jcem-53-1-209.
3
Identification of luteinizing hormone-releasing factor and alpha-subunit of glycoprotein hormones in human pancreatic islets.人胰岛中促黄体生成激素释放因子和糖蛋白激素α亚基的鉴定
Life Sci. 1980 Aug 4;27(5):395-7. doi: 10.1016/0024-3205(80)90187-3.
4
Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF).促黄体生成素(LH)与促卵泡生成素(FSH)综合水平与对促黄体生成素释放因子(LRF)反应之间的相关性。
J Clin Endocrinol Metab. 1976 Dec;43(6):1240-9. doi: 10.1210/jcem-43-6-1240.
5
Action of luteinizing hormone-releasing factor (lrf) in the initiation of lordosis behavior in the estrone-primed ovariectomized female rat.促黄体生成素释放因子(LRF)对雌激素预处理的去卵巢雌性大鼠弓背行为起始的作用。
Neuroendocrinology. 1975;17(4):309-18. doi: 10.1159/000122369.
6
Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.促性腺激素和α亚基对糖蛋白激素分泌型垂体瘤患者长期给予促性腺激素释放激素类似物的反应。
J Clin Endocrinol Metab. 1989 Jan;68(1):81-6. doi: 10.1210/jcem-68-1-81.
7
Effects of a superactive luteinizing hormone-releasing factor agonist on gonadotropin and ovarian function during the menstrual cycle.一种超活性促黄体生成素释放因子激动剂对月经周期中促性腺激素和卵巢功能的影响。
Am J Obstet Gynecol. 1979 Nov 15;135(6):759-63. doi: 10.1016/0002-9378(79)90388-0.
8
Immunohistochemical demonstration of luteinizing hormone-releasing factor-like material in human syncytiotrophoblast and trophoblastic tumours.人合体滋养层细胞和滋养层肿瘤中促黄体生成激素释放因子样物质的免疫组织化学显示
Clin Endocrinol (Oxf). 1980 May;12(5):441-51. doi: 10.1111/j.1365-2265.1980.tb02734.x.
9
Corticotropin-releasing hormone, luteinizing hormone-releasing hormone, growth hormone-releasing hormone, and somatostatin-like immunoreactivities in biopsies from breast cancer patients.乳腺癌患者活检组织中的促肾上腺皮质激素释放激素、促黄体生成素释放激素、生长激素释放激素及生长抑素样免疫反应性
Breast Cancer Res Treat. 1990 May;15(3):175-84. doi: 10.1007/BF01806354.
10
Changes in circulating levels of LH, FSH, LHbeta- and alpha-subunit after gonadotropin-releasing hormone, and of TSH, LHbeta- and alpha-subunit after thyrotropin-releasing hormone.促性腺激素释放激素刺激后促黄体生成素(LH)、促卵泡生成素(FSH)、LHβ亚基和α亚基的循环水平变化,以及促甲状腺激素释放激素刺激后促甲状腺激素(TSH)、LHβ亚基和α亚基的循环水平变化。
J Clin Endocrinol Metab. 1975 Sep;41(3):466-70. doi: 10.1210/jcem-41-3-466.

引用本文的文献

1
Characterization of binding sites for a GnRH-agonist (buserelin) in human breast cancer biopsies and their distribution in relation to tumor parameters.人乳腺癌活检中促性腺激素释放激素激动剂(布舍瑞林)结合位点的特征及其与肿瘤参数相关的分布情况。
Breast Cancer Res Treat. 1993;25(1):37-46. doi: 10.1007/BF00662399.
2
Inhibition of mammary tumor growth in rats and mice by administration of agonistic and antagonistic analogs of luteinizing hormone-releasing hormone.通过给予促黄体生成素释放激素的激动剂和拮抗剂类似物抑制大鼠和小鼠乳腺肿瘤生长。
Proc Natl Acad Sci U S A. 1983 Mar;80(5):1459-62. doi: 10.1073/pnas.80.5.1459.
3
Immunohistochemical localization of HCG and its subunits in testicular germ cell tumours.
人绒毛膜促性腺激素(HCG)及其亚基在睾丸生殖细胞肿瘤中的免疫组织化学定位
Virchows Arch A Pathol Anat Histopathol. 1985;406(3):333-8. doi: 10.1007/BF00704302.
4
Corticotropin-releasing hormone, luteinizing hormone-releasing hormone, growth hormone-releasing hormone, and somatostatin-like immunoreactivities in biopsies from breast cancer patients.乳腺癌患者活检组织中的促肾上腺皮质激素释放激素、促黄体生成素释放激素、生长激素释放激素及生长抑素样免疫反应性
Breast Cancer Res Treat. 1990 May;15(3):175-84. doi: 10.1007/BF01806354.